SCHEMBL5366003

SCHEMBL5366003

CNc1c(Cl)nc(C)n1-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
HSD17B10 Q99714 2/20 0.41
USP2 O75604 1/20 0.41
ALOX15 P16050 1/20 0.41
APOBEC3A P31941 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
TSHR P16473 1/20 0.41
ALDH1A1 P00352 2/20 0.40
HCAR1 Q9BXC0 1/20 0.39
PI4KA P42356 1/20 0.39
PI4K2B Q8TCG2 1/20 0.39
PI4K2A Q9BTU6 1/20 0.39
PI4KB Q9UBF8 1/20 0.39
GRM5 P41594 1/20 0.38
GRM1 Q13255 1/20 0.38
DCTPP1 Q9H773 1/20 0.38
CNR2 P34972 1/20 0.38
AVPR1A P37288 1/20 0.38
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5366123 0.85 AVPR1A (0.44) MAPK1HTTHSD17B10ALOX15APOBEC3G
SCHEMBL5366183 0.79 TSHR (0.48) MAPK1HTTHSD17B10USP2ALOX15
SCHEMBL5366008 0.76 MAPK1 (0.46) MAPK1HTTHSD17B10USP2ALOX15
SCHEMBL5376005 0.75 ALDH1A1 (0.49) MAPK1HTTHSD17B10USP2ALOX15
SCHEMBL5387360 0.72 MAPK1 (0.46) MAPK1HTTHSD17B10USP2ALOX15
SCHEMBL19365959 0.71 MAPK1 (0.52) MAPK1HTTHSD17B10USP2ALOX15
SCHEMBL5374567 0.69 HSD11B1 (0.42) HTTPI4KAPI4K2BPI4K2API4KB
SCHEMBL5369241 0.69 HTT (0.43) MAPK1HTTHSD17B10USP2ALOX15
SCHEMBL5376009 0.68 PI4KA (0.51) MAPK1HTTHSD17B10USP2ALOX15
SCHEMBL5374671 0.68 HTT (0.43) MAPK1HTTHSD17B10ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7238212-B2 Imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2007-07-03 US claimed
US-20050011019-A1 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2005-01-20 US claimed
EP-1484049-A1 Imidazole compounds and their use for dyeing of keratinous fibres L'OREAL (FR) 2004-12-08 EP claimed
US-7238212-B2 Imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2007-07-03 US disclosed
US-20050011019-A1 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers L'OREAL, S.A. (FR) 2005-01-20 US disclosed
EP-1484049-A1 Imidazole compounds and their use for dyeing of keratinous fibres L'OREAL (FR) 2004-12-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050011019-A1 Novel imidazole compounds and use of these compounds for dyeing keratinous fibers KRT18, VIM, NDUFS6 MAPK1 2658/4885HTT 4672/4885HSD17B10 1960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.